nomegestrol acetate,
TX 066,
TX-066,
Nomegestrol acetate,
58652-20-3,
Nomegestrol 17-acetate,
TX 066,
NOMAC,
Lutenyl,
Uniplant,
TX-066,
UNII-83J78V5W05,
EINECS 261-379-8,
Nomegestrol acetate [USAN],
MLS002154113,
83J78V5W05,
ORG 10486-0,
ORG-10486-0,
17-alpha-Acetoxy-6-methyl-19-nor-4,6-pregnadiene-3,20-dione,
19-Norpregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-,
17-alpha-Hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione acetate,
17-Hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione 17-acetate,
Nomegestrol acetate (USAN),
19-Norpregna-4,6-diene-3,20-dione, 17-alpha-hydroxy-6-methyl-, acetate,
[(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate,
Lutenyl (TN),
Surplant,
Nomegestrone acetate,
AC1L3MJM,
Prestwick3_001033,
SCHEMBL37517,
BSPBio_001245,
BPBio1_001370,
CHEMBL1476022,
17-acetoxy-6-methyl-19-norpregna-4,6-diene-3,20-dione,
DTXSID90207349,
CHEBI:135564,
17-(Acetyloxy)-6-methyl-19-norpregna-4,6-diene-3,20-dione,
HMS2098O07,
HMS2230M23,
HMS3715O07,
(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate,
BCP08358,
ZINC3938628,
CN0044,
MFCD00941390,
AKOS015896563,
Nomegestrol acetate, >=98% (HPLC),
AC-1119,
ACN-043354,
AN-6935,
CCG-221033,
NCGC00179247-01,
BC678124,
LS-97336,
SMR001233420,
AB00514012,
D08281,
6-Methyl-17.alpha.-acetoxy-6-19-norprogesterone,
652N203,
C-21132,
SR-01000841206,
I06-2402,
SR-01000841206-2,
W-105372,
BRD-K27351809-001-02-0,
19-Norpregna-4,6-diene-3,20-dione,17-(acetyloxy)-6-methyl-,
(17alpha)-17-Acetyl-6-methyl-3-oxoestra-4,6-dien-17-yl acetate,
Nomegestrol acetate, European Pharmacopoeia (EP) Reference Standard,
17-alpha-hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dioneacetate,
(8S,9S,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate,
D0V2JK,
C23H30O4,
CID91668,
AR-1C1039,
C23-H30-O4,
C038501,
6037-79-2,